BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 17896770)

  • 1. Poly(3-hydroxybutyrate-co-3-hydroxyvalerate)/poly(epsilon-caprolactone) blends for tissue engineering applications in the form of hollow fibers.
    Chiono V; Ciardelli G; Vozzi G; Sotgiu MG; Vinci B; Domenici C; Giusti P
    J Biomed Mater Res A; 2008 Jun; 85(4):938-53. PubMed ID: 17896770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blends of poly-(epsilon-caprolactone) and polysaccharides in tissue engineering applications.
    Ciardelli G; Chiono V; Vozzi G; Pracella M; Ahluwalia A; Barbani N; Cristallini C; Giusti P
    Biomacromolecules; 2005; 6(4):1961-76. PubMed ID: 16004434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of chitosan-polycaprolactone blends for tissue engineering applications.
    Sarasam A; Madihally SV
    Biomaterials; 2005 Sep; 26(27):5500-8. PubMed ID: 15860206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New poly(epsilon-caprolactone)/chitosan blend fibers for tissue engineering applications.
    Malheiro VN; Caridade SG; Alves NM; Mano JF
    Acta Biomater; 2010 Feb; 6(2):418-28. PubMed ID: 19607943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cellular proliferation on dense and porous PCL scaffolds.
    Saşmazel HT; Gümüşderelioğlu M; Gürpinar A; Onur MA
    Biomed Mater Eng; 2008; 18(3):119-28. PubMed ID: 18725692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyurethane/polycaprolactane blend with shape memory effect as a proposed material for cardiovascular implants.
    Ajili SH; Ebrahimi NG; Soleimani M
    Acta Biomater; 2009 Jun; 5(5):1519-30. PubMed ID: 19249261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of thermal treatments to enhance the mechanical properties of electrospun poly(epsilon-caprolactone) scaffolds.
    Lee SJ; Oh SH; Liu J; Soker S; Atala A; Yoo JJ
    Biomaterials; 2008 Apr; 29(10):1422-30. PubMed ID: 18096219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rate-modulating PHBHV/PCL microparticles containing weak acid model drugs.
    Poletto FS; Jäger E; Ré MI; Guterres SS; Pohlmann AR
    Int J Pharm; 2007 Dec; 345(1-2):70-80. PubMed ID: 17604922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of poly(epsilon-caprolactone)/polyfumarate blends as scaffolds for bone tissue engineering.
    Fernandez JM; Molinuevo MS; Cortizo AM; McCarthy AD; Cortizo MS
    J Biomater Sci Polym Ed; 2010; 21(10):1297-312. PubMed ID: 20534186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface properties and biocompatibility of solvent-cast poly[-caprolactone] films.
    Tang ZG; Black RA; Curran JM; Hunt JA; Rhodes NP; Williams DF
    Biomaterials; 2004 Aug; 25(19):4741-8. PubMed ID: 15120520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocompatibility of Poly(epsilon-caprolactone) scaffold modified by chitosan--the fibroblasts proliferation in vitro.
    Mei N; Chen G; Zhou P; Chen X; Shao ZZ; Pan LF; Wu CG
    J Biomater Appl; 2005 Apr; 19(4):323-39. PubMed ID: 15788428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of bio-compatibility via specific interactions in polyesters modified with a bio-resourceful macromolecular ester containing polyphenol groups.
    Yen KC; Mandal TK; Woo EM
    J Biomed Mater Res A; 2008 Sep; 86(3):701-12. PubMed ID: 18041717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of nanofibrous scaffolds containing gum tragacanth/poly (ε-caprolactone) for application as skin scaffolds.
    Ranjbar-Mohammadi M; Bahrami SH
    Mater Sci Eng C Mater Biol Appl; 2015 Mar; 48():71-9. PubMed ID: 25579898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan/poly(epsilon-caprolactone) blend scaffolds for cartilage repair.
    Neves SC; Moreira Teixeira LS; Moroni L; Reis RL; Van Blitterswijk CA; Alves NM; Karperien M; Mano JF
    Biomaterials; 2011 Feb; 32(4):1068-79. PubMed ID: 20980050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrospun poly(epsilon-caprolactone)/gelatin nanofibrous scaffolds for nerve tissue engineering.
    Ghasemi-Mobarakeh L; Prabhakaran MP; Morshed M; Nasr-Esfahani MH; Ramakrishna S
    Biomaterials; 2008 Dec; 29(34):4532-9. PubMed ID: 18757094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Composition dependence of the crystallization behavior and morphology of the poly(ethylene oxide)-poly(epsilon-caprolactone) diblock copolymer.
    He C; Sun J; Ma J; Chen X; Jing X
    Biomacromolecules; 2006 Dec; 7(12):3482-9. PubMed ID: 17154478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ orientation studies of a poly(3-hydroxybutyrate)/poly(epsilon-caprolactone) blend by rheo-optical fourier transform infrared spectroscopy and two-dimensional correlation spectroscopic analysis.
    Unger M; Siesler HW
    Appl Spectrosc; 2009 Dec; 63(12):1351-5. PubMed ID: 20030979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gravity spun polycaprolactone fibres for soft tissue engineering: interaction with fibroblasts and myoblasts in cell culture.
    Williamson MR; Adams EF; Coombes AG
    Biomaterials; 2006 Mar; 27(7):1019-26. PubMed ID: 16054685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of elastin on chondrocyte adhesion and proliferation on poly (ɛ-caprolactone)/elastin composites.
    Annabi N; Fathi A; Mithieux SM; Martens P; Weiss AS; Dehghani F
    Biomaterials; 2011 Feb; 32(6):1517-25. PubMed ID: 21115195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reinforcing poly(epsilon-caprolactone) nanofibers with cellulose nanocrystals.
    Zoppe JO; Peresin MS; Habibi Y; Venditti RA; Rojas OJ
    ACS Appl Mater Interfaces; 2009 Sep; 1(9):1996-2004. PubMed ID: 20355825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.